LF
Lansforsakringar Fondforvaltning Portfolio holdings
AUM
$17.4B
This Quarter Return
+5.38%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$17.9B
AUM Growth
–
Cap. Flow
+$17.9B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
37.62%
Holding
563
New
563
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$1.3B |
| 2 |
NVIDIA
NVDA
|
$1.29B |
| 3 |
Microsoft
MSFT
|
$1.18B |
| 4 |
Amazon
AMZN
|
$866M |
| 5 |
Meta Platforms (Facebook)
META
|
$418M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 34.54% |
| 2 | Financials | 14.24% |
| 3 | Consumer Discretionary | 12.68% |
| 4 | Healthcare | 10.4% |
| 5 | Communication Services | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Nutrien
NTR
$27.9B
| $4.95M | 0.03% |
+110,770
| New | +$4.95M |
|
402
Pultegroup
PHM
$26B
| $4.88M | 0.03% |
+44,836
| New | +$4.88M |
|
403
Tradeweb Markets
TW
$26.4B
| $4.88M | 0.03% |
+37,263
| New | +$4.88M |
|
404
Cameco
CCJ
$32.7B
| $4.84M | 0.03% |
+94,208
| New | +$4.84M |
|
405
Avery Dennison
AVY
$13.2B
| $4.83M | 0.03% |
+25,800
| New | +$4.83M |
|
406
Healthpeak Properties
DOC
$12.4B
| $4.81M | 0.03% |
+237,079
| New | +$4.81M |
|
407
JB Hunt Transport Services
JBHT
$13.9B
| $4.79M | 0.03% |
+28,081
| New | +$4.79M |
|
408
United Therapeutics
UTHR
$18.5B
| $4.78M | 0.03% |
+13,541
| New | +$4.78M |
|
409
Prudential Financial
PRU
$37.6B
| $4.78M | 0.03% |
+40,300
| New | +$4.78M |
|
410
Viatris
VTRS
$12.3B
| $4.77M | 0.03% |
+383,285
| New | +$4.77M |
|
411
Reliance Steel & Aluminium
RS
$15.2B
| $4.75M | 0.03% |
+17,626
| New | +$4.75M |
|
412
Howmet Aerospace
HWM
$69.9B
| $4.73M | 0.03% |
+43,292
| New | +$4.73M |
|
413
F5
FFIV
$17.6B
| $4.7M | 0.03% |
+18,676
| New | +$4.7M |
|
414
Domino's
DPZ
$15.8B
| $4.64M | 0.03% |
+11,065
| New | +$4.64M |
|
415
Pembina Pipeline
PBA
$21.7B
| $4.63M | 0.03% |
+125,354
| New | +$4.63M |
|
416
Aecom
ACM
$16.5B
| $4.59M | 0.03% |
+42,956
| New | +$4.59M |
|
417
Graco
GGG
$14B
| $4.56M | 0.03% |
+54,126
| New | +$4.56M |
|
418
Moderna
MRNA
$9.4B
| $4.49M | 0.03% |
+107,880
| New | +$4.49M |
|
419
Fortis
FTS
$24.9B
| $4.44M | 0.02% |
+106,986
| New | +$4.44M |
|
420
Neurocrine Biosciences
NBIX
$14.1B
| $4.43M | 0.02% |
+32,446
| New | +$4.43M |
|
421
Revvity
RVTY
$10.1B
| $4.41M | 0.02% |
+39,518
| New | +$4.41M |
|
422
Okta
OKTA
$15.7B
| $4.37M | 0.02% |
+55,508
| New | +$4.37M |
|
423
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.37M | 0.02% |
+66,436
| New | +$4.37M |
|
424
Restaurant Brands International
QSR
$20.5B
| $4.33M | 0.02% |
+66,428
| New | +$4.33M |
|
425
Rollins
ROL
$27.4B
| $4.32M | 0.02% |
+93,108
| New | +$4.32M |
|